Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Servier researchers identify new metalloproteinase inhibitors

Aug. 8, 2002

Bayer claims new PDE10A inhibitors and their use in cancer

Aug. 8, 2002

AstraZeneca completes Iressa NDA for NSCLC

Aug. 8, 2002

Positive results for ursodiol in colorectal cancer

Aug. 8, 2002

Introgen to file European Advexin marketing application in 2004

Aug. 8, 2002

Atrix submits IND for new dosage form of Eligard

Aug. 8, 2002

Patient enrollment completed for phase III clinical trial with Tarceva

Aug. 7, 2002

Potential role for CEP-701 in the treatment of acute myeloid leukemia

Aug. 7, 2002

Novel topoisomerase I inhibitors in Advanced Life Sciences pipeline

Aug. 6, 2002

MTC-DOX designated orphan drug in E.U.

Aug. 6, 2002

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...